These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 16487852)
21. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system. Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191 [TBL] [Abstract][Full Text] [Related]
22. Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-Q(92), responsible for human hypertrophic cardiomyopathy. Lim DS; Oberst L; McCluggage M; Youker K; Lacy J; DeMayo F; Entman ML; Roberts R; Michael LH; Marian AJ J Mol Cell Cardiol; 2000 Mar; 32(3):365-74. PubMed ID: 10731436 [TBL] [Abstract][Full Text] [Related]
23. Characterization and validation of a preventative therapy for hypertrophic cardiomyopathy in a murine model of the disease. Viola HM; Shah AA; Johnstone VPA; Cserne Szappanos H; Hodson MP; Hool LC Proc Natl Acad Sci U S A; 2020 Sep; 117(37):23113-23124. PubMed ID: 32859761 [TBL] [Abstract][Full Text] [Related]
24. Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy. Nagueh SF; Chen S; Patel R; Tsybouleva N; Lutucuta S; Kopelen HA; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ J Mol Cell Cardiol; 2004 May; 36(5):663-73. PubMed ID: 15135661 [TBL] [Abstract][Full Text] [Related]
25. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. Oberst L; Zhao G; Park JT; Brugada R; Michael LH; Entman ML; Roberts R; Marian AJ J Clin Invest; 1998 Oct; 102(8):1498-505. PubMed ID: 9788962 [TBL] [Abstract][Full Text] [Related]
26. N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats. Bourraindeloup M; Adamy C; Candiani G; Cailleret M; Bourin MC; Badoual T; Su JB; Adubeiro S; Roudot-Thoraval F; Dubois-Rande JL; Hittinger L; Pecker F Circulation; 2004 Oct; 110(14):2003-9. PubMed ID: 15451797 [TBL] [Abstract][Full Text] [Related]
27. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Maass AH; Ikeda K; Oberdorf-Maass S; Maier SK; Leinwand LA Circulation; 2004 Oct; 110(15):2102-9. PubMed ID: 15466629 [TBL] [Abstract][Full Text] [Related]
28. Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice. Lu D; Ma Y; Zhang W; Bao D; Dong W; Lian H; Huang L; Zhang L Hypertension; 2012 Jul; 60(1):81-9. PubMed ID: 22665122 [TBL] [Abstract][Full Text] [Related]
29. S100A4 and P53 in myocardial collagen fibers of hypertrophic cardiomyopathy : Expression and clinical significance. Qi X; Han J; Zhao P; Dong X; Gong S Herz; 2016 Sep; 41(6):530-3. PubMed ID: 26781584 [TBL] [Abstract][Full Text] [Related]
30. [Changes of left ventricular myocardial collagen fibers and osteopontin expression in hypertrophic cardiomyopathy]. Tang DW; Lin GS; Huang JL; Liu C; Hao B; Yu YG; Kong XP; Quan L; Liao XB; Luo B Fa Yi Xue Za Zhi; 2012 Aug; 28(4):247-51. PubMed ID: 23033660 [TBL] [Abstract][Full Text] [Related]
31. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954 [TBL] [Abstract][Full Text] [Related]
32. Molecular genetics and pathogenesis of hypertrophic cardiomyopathy. Marian AJ; Salek L; Lutucuta S Minerva Med; 2001 Dec; 92(6):435-51. PubMed ID: 11740432 [TBL] [Abstract][Full Text] [Related]
33. Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy. Almaas VM; Haugaa KH; Strøm EH; Scott H; Smith HJ; Dahl CP; Geiran OR; Endresen K; Aakhus S; Amlie JP; Edvardsen T Heart; 2014 Apr; 100(8):631-8. PubMed ID: 24368281 [TBL] [Abstract][Full Text] [Related]
34. [Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling]. Coppini R; Ferrantini C; Poggesi C; Mugelli A; Olivotto I G Ital Cardiol (Rome); 2016 Mar; 17(3):189-96. PubMed ID: 27029877 [TBL] [Abstract][Full Text] [Related]
35. Antifibrotic and antioxidant effects of N-acetylcysteine in an experimental cholestatic model. Galicia-Moreno M; Favari L; Muriel P Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):179-85. PubMed ID: 22241216 [TBL] [Abstract][Full Text] [Related]
36. A comprehensive evaluation of myocardial fibrosis in hypertrophic cardiomyopathy with cardiac magnetic resonance imaging: linking genotype with fibrotic phenotype. Ellims AH; Iles LM; Ling LH; Chong B; Macciocca I; Slavin GS; Hare JL; Kaye DM; Marasco SF; McLean CA; James PA; du Sart D; Taylor AJ Eur Heart J Cardiovasc Imaging; 2014 Oct; 15(10):1108-16. PubMed ID: 24819852 [TBL] [Abstract][Full Text] [Related]
37. Prognostic value of the collagen volume fraction in hypertrophic cardiomyopathy. Arteaga E; de Araújo AQ; Bernstein M; Ramires FJ; Ianni BM; Fernandes F; Mady C Arq Bras Cardiol; 2009 Mar; 92(3):210-4, 216-20. PubMed ID: 19390710 [TBL] [Abstract][Full Text] [Related]
38. The changes of the cardiac structure and function in cTnTR141W transgenic mice. Juan F; Wei D; Xiongzhi Q; Ran D; Chunmei M; Lan H; Chuan Q; Lianfeng Z Int J Cardiol; 2008 Aug; 128(1):83-90. PubMed ID: 18606313 [TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy. Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501 [TBL] [Abstract][Full Text] [Related]
40. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]